Finance News – Eli Lilly
What is your interest today?
Tariffs
Ceo
Investors
Stock
Earnings
Shares
Markets
Stocks
China
Trade
Investment
Revenue
Nasdaq
Economy
Wall street
Stock market
Warren buffett
Eqs
Berkshire hathaway
Trade war
Nvidia
Inflation
Prices
Cet
U.s.
Company
Amazon
Apple
Guidance
Sales
Class action
Federal reserve
S&p 500
Securities
Bitcoin
Ipo
Trading
Corporate
Crypto
Recession
Tesla
Forecast
Microsoft
Companies
Interest rates
Gold
Imports
Business
Shareholders
Coinbase
Economic uncertainty
International
Unh
Geron corporation
Entry-level
Aon
Bureau of economic analysis
Allowance
Article 17 mar
Credit rating
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0
px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400
text-gray-900 dark:text-gray-100 mr-2"
/>
Quartz • May 12, 2025
Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →
Quartz • May 12, 2025
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...
Read Full Article →